Results 1 to 10 of about 48,421 (285)

Cardiac amyloidosis

Swiss Medical Weekly
Cardiac amyloidosis is a disease characterised by the accumulation of amyloid protein in the heart tissue. There are several types of amyloidosis, but the most common types affecting the heart are ATTR amyloidosis (caused by transthyretin protein) and ...
Natallia Laptseva, Dominik C. Benz, Rahel Schwotzer, Andreas J. Flammer   +3 more
doaj   +7 more sources

Role of cardiac MRI in the diagnosis of cardiac amyloidosis. Clinical cases

Клинический разбор в общей медицине, 2021
Purpose. The aim of this work is to show the capabilities of late gadolinium enhancement cardiac magnetic resonance imaging (MRI) in the diagnosis of a rare disease such as cardiac amyloidosis. Materials and methods.
Ekaterina A. Butorova , Olga V. Stukalova   +1 more
doaj   +2 more sources

Cardiac amyloidosis

EXCLI Journal : Experimental and Clinical Sciences, 2023
Amyloidosis is a protein deposition disorder in which insoluble fibril structures accumulate in the bodily tissues damaging the organ function. Cardiac amyloidosis is a severe but under-reported medical condition characterized by the accumulation of ...
Gnana Deepthi Medarametla, Ripudaman Singh Kahlon, Lampimukhi Mahitha, Sanobar Shariff, Naga Praneeth Vakkalagadda, Hitesh Chopra, Mohammad Amjad Kamal, Neil Patel, Yashendra Sethi, Nirja Kaka   +9 more
doaj   +6 more sources

Cardiac amyloidosis presenting as recurrent acute coronary syndrome with unobstructed coronary arteries: Case report

Indian Heart Journal, 2015
Amyloidosis is a systemic disorder characterized by the deposition of mis-folded protein molecules within various organs. Cardiac involvement may be the presenting feature of this condition or may be identified incidentally during investigation for ...
Anish George, Brian McClements
doaj   +2 more sources

Base-to-apex gradient pattern of cardiac impairment identified on myocardial T1 mapping in cardiac amyloidosis

Radiology Case Reports, 2019
Late gadolinium enhancement imaging by cardiac magnetic resonance imaging (CMR) is the most reliable method for identifying cardiac involvement in patients with amyloidosis, and myocardial T1 mapping is a novel CMR technique that enables the noninvasive ...
Seitaro Oda, MD, PhD, Yawara Kawano, MD, PhD, Yutaka Okuno, MD, PhD, Daisuke Utsunomiya, MD, PhD, Takeshi Nakaura, MD, PhD, Kenichi Tsujita, MD, PhD, Yasuyuki Yamashita, MD, PhD   +6 more
doaj   +2 more sources

Cardiac Amyloidosis

Heart Failure Clinics, 2022
Amyloid deposits are defined by their tinctorial properties. Under the light microscope amyloid deposits are eosinophilic and amorphous when stained with hematoxylin and eosin. With Congo red staining the deposits are positive and under polarized light will exhibit green birefringence.
T, Tadokoro, H, Yamamoto, Y, Hyakuna, M, Mohri   +3 more
  +6 more sources

Cardiac amyloidosis [PDF]

QJM: An International Journal of Medicine, 2018
Systemic amyloidosis comprises an uncommon group of disorders caused by the extracellular deposition of misfolded proteins in various organs. Cardiac amyloid deposition, causing an infiltrative/restrictive cardiomyopathy, is a frequent feature of amyloidosis and a major determinant of survival.
C H, Yu, Y H, Lu, J H, Lu
openaire   +6 more sources

Cardiac amyloidosis [PDF]

Clinical Medicine, 2005
Systemic amyloidosis commonly affects the heart. Indeed, cardiac symptoms may be the first clinical indicator of underlying amyloid deposition. Using two case studies, this article reviews the latest evidence regarding cardiac amyloidosis. The diagnosis of cardiac involvement can be established through imaging with echocardiography and magnetic ...
Maredia, Neil, Ray, Simon G
openaire   +4 more sources

AL Cardiac Amyloidosis Presenting as Grade 3 ATTR Mimicry on Scintigraphy [PDF]

JACC Case Rep
Zambrano Zambrano K, Martínez Salazar J, Velarde Michaud J, Bernal Alferes B, Ortega Martínez E, Fernández Sánchez C, Montiel López L, Zambrano Zambrano A.   +7 more
europepmc   +2 more sources

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis

Transplantation Direct, 2022
Background. Heart transplantation in cardiac amyloidosis (CA) patients is possible and generally considered for transplantation if other organs are not affected.
Soulef Guendouz, MD, Philippe Grimbert, MD, PhD, Costin Radu, MD, PhD, Daniel Cherqui, MD, PhD, Chady Salloum, MD, Nicolas Mongardon, MD, PhD, Sami Maghrebi, MD, Karim Belhadj, MD, Fabien Le Bras, MD, Emmanuel Teiger, MD, PhD, Jean-Paul Couetil, MD, PhD, Adriana Balan, MD, Mounira Kharoubi, MSc, Mélanie Bézard, MSc, Silvia Oghina, MD, Diane Bodez, MD, PhD, Luc Hittinger, MD, PhD, Vincent Audard, MD, PhD, Violaine Planté-Bordeneuve, MD, PhD, Alexandre De la Taille, MD, PhD, Eric Bergoend, MD, Valerie Frenkel, MD, PhD, Pascale Fanen, MD, PhD, Vincent Leroy, MD, PhD, Christophe Duvoux, MD, PhD, Maryvonnick Carmagnat, PharmD, Thierry Folliguet, MD, PhD, Thibaud Damy, MD, PhD   +27 more
doaj   +1 more source